-
E649524-5mgErtiprotafib is an inhibitor of PTP1B, IkB kinase β (IKK-β) , and a dual PPARα and PPARβ agonist, with an IC 50 of 1.6 μM for PTP1B, 400 nM for IKK-β , an EC 50 of ~1 μM for PPARα/PPARβ.In VitroErtiprotafib is a potent inhibitor of IKK-β, with an IC
-
E650038-10mgERα degrader-2 is a selective estrogen receptor degrader ( SERD ) with potent binding affinity with ERα ( IC 50 =17.1 nM), good degradation efficacy ( EC 50 =0.3 nM). ERα degrader-2 exhibits favorable pharmacokinetic properties and excellent
-
E650038-25mgERα degrader-2 is a selective estrogen receptor degrader ( SERD ) with potent binding affinity with ERα ( IC 50 =17.1 nM), good degradation efficacy ( EC 50 =0.3 nM). ERα degrader-2 exhibits favorable pharmacokinetic properties and excellent
-
E650038-5mgERα degrader-2 is a selective estrogen receptor degrader ( SERD ) with potent binding affinity with ERα ( IC 50 =17.1 nM), good degradation efficacy ( EC 50 =0.3 nM). ERα degrader-2 exhibits favorable pharmacokinetic properties and excellent
-
E129653-1gEsomeprazole Magnesium is a proton pump inhibitor to reduce gastric acid secretion.
-
E129653-250mgEsomeprazole Magnesium is a proton pump inhibitor to reduce gastric acid secretion.
-
E129653-25gEsomeprazole Magnesium is a proton pump inhibitor to reduce gastric acid secretion.
-
E129653-5gEsomeprazole Magnesium is a proton pump inhibitor to reduce gastric acid secretion.
-
E305090-100gEsomeprazole sodium.
-
E305090-1gEsomeprazole sodium.
-
E305090-250mgEsomeprazole sodium.
-
E305090-25gEsomeprazole sodium.